Galapagos NV
GLPG
#4563
Rank
NZ$3.65 B
Marketcap
NZ$54.68
Share price
-0.57%
Change (1 day)
19.35%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$2.16 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are NZ$2.16 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$2.28 B-16.28%
2023-12-31NZ$2.73 B-26.83%
2022-12-31NZ$3.73 B-11.75%
2021-12-31NZ$4.22 B-18.62%
2020-12-31NZ$5.19 B-2.19%
2019-12-31NZ$5.31 B1282.51%
2018-12-31NZ$0.38 B-17.1%
2017-12-31NZ$0.46 B-6%
2016-12-31NZ$0.49 B298.08%
2015-12-31NZ$0.12 B24.01%
2014-12-31NZ$99.85 M-50.58%
2013-12-31NZ$0.20 B7.51%
2012-12-31NZ$0.18 B164.65%
2011-12-31NZ$71.01 M-9.38%
2010-12-31NZ$78.36 M14.06%
2009-12-31NZ$68.7 M-17.33%
2008-12-31NZ$83.11 M-12.97%
2007-12-31NZ$95.49 M-12.25%
2006-12-31NZ$0.10 B207.39%
2005-12-31NZ$35.4 M254.99%
2004-12-31NZ$9.97 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
NZ$118.54 B 5,379.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
NZ$196.53 B 8,984.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$114.29 B 5,182.97%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
NZ$236.27 B 10,821.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
NZ$0.21 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$56.97 B 2,533.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.43 B 2,508.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$106.08 B 4,803.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
NZ$134.39 B 6,112.06%๐Ÿ‡บ๐Ÿ‡ธ USA